Signal Transduction and Targeted Therapy, Published online: 20 November 2026; doi:10.1038/s41392-026-03093-6 Peroxiredoxin 3 deficiency promotes age-dependent dopaminergic neurodegeneration with mitochondrial redox abnormalities and oxidized dopamine-associated fluorescence
Seong Keun Sonn, Jee-Hyun Um, Minseo Woo, Hyejin Park, Jeanho Yun, Goo Taeg Oh. Peroxiredoxin 3 deficiency promotes age-dependent dopaminergic neurodegeneration with mitochondrial redox abnormalities and oxidized dopamine-associated fluorescence. // Signal Transduction and Targeted Therapy. – 2026. – DOI: 10.1038/s41392-026-03093-6. – URL: https://www.nature.com/articles/s41392-026-03093-6
Seong Keun Sonn, Jee-Hyun Um, Minseo Woo, Hyejin Park, Jeanho Yun, & Goo Taeg Oh (2026). Peroxiredoxin 3 deficiency promotes age-dependent dopaminergic neurodegeneration with mitochondrial redox abnormalities and oxidized dopamine-associated fluorescence. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-026-03093-6
Seong Keun Sonn, et al. “Peroxiredoxin 3 deficiency promotes age-dependent dopaminergic neurodegeneration with mitochondrial redox abnormalities and oxidized dopamine-associated fluorescence.” Signal Transduction and Targeted Therapy, 2026. doi:10.1038/s41392-026-03093-6.
@article{Sonn2026,
title = {Peroxiredoxin 3 deficiency promotes age-dependent dopaminergic neurodegeneration with mitochondrial redox abnormalities and oxidized dopamine-associated fluorescence},
author = {Sonn, Seong Keun and Um, Jee-Hyun and Woo, Minseo and Park, Hyejin and Yun, Jeanho and Oh, Goo Taeg},
journal = {Signal Transduction and Targeted Therapy},
year = {2026},
doi = {10.1038/s41392-026-03093-6},
url = {https://www.nature.com/articles/s41392-026-03093-6}
}